UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 263

Sortiert nach

Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

Journal of clinical oncology, 2001-01, Vol.19 (2), p.305-313

2001

Link zum Volltext

Verfügbarkeit prüfen

Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report

Journal of clinical oncology, 1993-06, Vol.11 (6), p.1118-1123

1993

Link zum Volltext

Verfügbarkeit prüfen

Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma

Journal of clinical oncology, 1994-05, Vol.12 (5), p.946-953

1994

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy in head and neck cancer. Overview of newer agents

Hematology/oncology clinics of North America, 1999-08, Vol.13 (4), p.753

1999

Link zum Volltext

Verfügbarkeit prüfen

Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer

Seminars in oncology, 1995-06, Vol.22 (3), p.24-27

1995

Link zum Volltext

Verfügbarkeit prüfen

Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus

Journal of clinical oncology, 1990-01, Vol.8 (1), p.119-127

1990

Link zum Volltext

Verfügbarkeit prüfen

Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma

Cancer, 1992-01, Vol.69 (2), p.285-291

1992

Link zum Volltext

Verfügbarkeit prüfen

Nonpharmacologic Pain Management in Terminal Care

Clinics in geriatric medicine, 1996-05, Vol.12 (2), p.301-311

Urba, Susan G.

1996

Link zum Volltext

Verfügbarkeit prüfen

Split‐course accelerated radiation therapy combined with carboplatin and 5‐fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus

Cancer, 1995-01, Vol.75 (2), p.435-439

1995

Link zum Volltext

Verfügbarkeit prüfen

Intensive recombinant interleukin‐2 and alpha‐interferon therapy in patients with advanced head and neck squamous carcinoma

Cancer, 1993-04, Vol.71 (7), p.2326-2331

1993

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Therapy for Organ Preservation in Head and Neck Cancer

The Laryngoscope, 2000-12, Vol.110 (12), p.2074-2080

2000

Link zum Volltext

Verfügbarkeit prüfen

Adult cancer pain

Journal of the National Comprehensive Cancer Network, 2013-08, Vol.11 (8), p.992

2013

Link zum Volltext

Verfügbarkeit prüfen

Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer

International journal of radiation oncology, biology, physics, 2005-12, Vol.63 (5), p.1395-1399

2005

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen Therapy In Patients With Recurrent Laryngeal Squamous Carcinoma

The Laryngoscope, 1990-01, Vol.100 (1), p.76-78

1990

Link zum Volltext

Verfügbarkeit prüfen

Organ Preservation for Advanced Resectable Cancer of the Base of Tongue and Hypopharynx: A Southwest Oncology Group Trial

Journal of clinical oncology, 2005-01, Vol.23 (1), p.88-95

2005

Link zum Volltext

Verfügbarkeit prüfen

Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma

Cancer, 2003-11, Vol.98 (10), p.2177-2183

2003

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy of head and neck cancer: most effective agents, areas of promise

Oncology (Williston Park, N.Y.), 1989-04, Vol.3 (4), p.79

1989

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of sorafenib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC): A Southwest Oncology Group (SWOG) trial

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.6044-6044

2007

Link zum Volltext

Verfügbarkeit prüfen

S0216: A Southwest Oncology Group (SWOG) phase II trial of docetaxel (T), cisplatin (P), and fluorouracil (F) induction followed by accelerated fractionation/concomitant boost (AF/CB) radiotherapy (RT) and concurrent cisplatin for advanced head and neck squamous cell cancer (HNSCC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.6014-6014

2007

Link zum Volltext

Verfügbarkeit prüfen

Experimental therapeutic approaches for recurrent head and neck cancer

Cancer treatment and research, 1995, Vol.74, p.263

1995

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of tetrathiomolybdate (TM) in metastatic head & neck cancer (MHNC) patients (pts) after treatment with platinum & 5-fluorouracil (P&5FU)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6080-6080

2008

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of BAY 43–9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC): A Southwest Oncology Group (SWOG) trial

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.5550-5550

2006

Link zum Volltext

Verfügbarkeit prüfen

Chemo-selection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.6005-6005

2007

Link zum Volltext

Verfügbarkeit prüfen

A phase II evaluation of a 3-hour infusion of paclitaxel (P), cisplatin (CDDP) & 5-fluorouracil (5FU) in patients with advanced or recurrent squamous cell carcinoma of the head & neck (SCCHN): A Southwest Oncology Group Study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5512-5512

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase II evaluation of a 3-hour infusion of paclitaxel (P), cisplatin (CDDP) & 5-fluorouracil (5FU) in patients with advanced or recurrent squamous cell carcinoma of the head & neck (SCCHN): A Southwest Oncology Group Study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5512-5512

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(257)
Mit Volltextzugriff
(201)

Publikationsform

Artikel
(261)
Tagungsberichte
(2)

Sprache

Englisch
(262)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(168)
Science & Technology
(156)
Life Sciences & Biomedicine
(150)
Oncology
(104)
Biological And Medical Sciences
(87)
Female
(84)
Medical Sciences
(81)
Male
(78)
Middle Aged
(76)
Aged
(63)
Adult
(62)
Pharmacology. Drug Treatments
(53)
Antineoplastic Agents
(47)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(42)
Immunotherapy
(31)
Chemotherapy
(29)
Combined Modality Therapy
(29)
Treatment Outcome
(28)
Neoplasms - Therapy
(27)
Carcinoma, Squamous Cell - Drug Therapy
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report

Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma

Chemotherapy in head and neck cancer. Overview of newer agents

Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer

Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus

Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma

Nonpharmacologic Pain Management in Terminal Care

Split‐course accelerated radiation therapy combined with carboplatin and 5‐fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus

Intensive recombinant interleukin‐2 and alpha‐interferon therapy in patients with advanced head and neck squamous carcinoma

Neoadjuvant Therapy for Organ Preservation in Head and Neck Cancer

Adult cancer pain

Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer

Tamoxifen Therapy In Patients With Recurrent Laryngeal Squamous Carcinoma

Organ Preservation for Advanced Resectable Cancer of the Base of Tongue and Hypopharynx: A Southwest Oncology Group Trial

Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma

Systemic therapy of head and neck cancer: most effective agents, areas of promise

A phase II trial of sorafenib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC): A Southwest Oncology Group (SWOG) trial

S0216: A Southwest Oncology Group (SWOG) phase II trial of docetaxel (T), cisplatin (P), and fluorouracil (F) induction followed by accelerated fractionation/concomitant boost (AF/CB) radiotherapy (RT) and concurrent cisplatin for advanced head and neck squamous cell cancer (HNSCC)

Experimental therapeutic approaches for recurrent head and neck cancer

A phase II trial of tetrathiomolybdate (TM) in metastatic head & neck cancer (MHNC) patients (pts) after treatment with platinum & 5-fluorouracil (P&5FU)

A phase II trial of BAY 43–9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC): A Southwest Oncology Group (SWOG) trial

Chemo-selection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma

A phase II evaluation of a 3-hour infusion of paclitaxel (P), cisplatin (CDDP) & 5-fluorouracil (5FU) in patients with advanced or recurrent squamous cell carcinoma of the head & neck (SCCHN): A Southwest Oncology Group Study

A phase II evaluation of a 3-hour infusion of paclitaxel (P), cisplatin (CDDP) & 5-fluorouracil (5FU) in patients with advanced or recurrent squamous cell carcinoma of the head & neck (SCCHN): A Southwest Oncology Group Study

Suchergebnisse filtern